Investors With Losses Are Invited To Join The Schall Law Firm In An Inquiry Into Singular Genomics Systems, Inc. For Securities Fraud

Core Viewpoint - The Schall Law Firm is inviting investors who have incurred losses to participate in an inquiry regarding Singular Genomics Systems, Inc. for potential securities fraud [1] Group 1 - The inquiry is focused on potential securities fraud involving Singular Genomics Systems, Inc. [1] - Investors who have suffered losses are encouraged to join the investigation [1] - The Schall Law Firm is known for its focus on securities fraud cases [1]